FDA Inspection 1324668 — Sun Young Rha, M.D., Ph.D.
The FDA completed an inspection of Sun Young Rha, M.D., Ph.D. on Jun 12, 2026 in Seodaemun. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 12, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Seodaemun (Korea (the Republic of))
Additional details
Clinical Investigator (CI)